Home > Category > Signaling Pathways > Proteases > Farnesyl Transferase > Lapaquistat acetate (Synonyms: TAK-475)

2-(1-(2-((3R,5S)-1-(3-乙酰氧基-2,2-二甲基丙基)-7-氯-5-(2,3-二甲氧基苯基)-2-氧代-1,2,3,5-四氢苯并[e][1,4]氧氮杂卓-3-基)乙酰基)哌啶-4-基)乙酸

ChemLeader 98+%
Catalog No:CL3134 CAS No.:189060-13-7 MDLNo:MFCD06407873 Formula:C33H41ClN2O9 MW:645.14
Size Availability Price(USD) VIP Price (USD) Quantity
1 mg 3-5 days ¥1488.00 Visible after login
- +
2 mg 3-5 days ¥2266.00 Visible after login
- +
5 mg 3-5 days ¥3626.00 Visible after login
- +

Chemical safety data sheet(MSDS)

Download MSDS
  • Product Overview
  • Related documents
  • Product details
  • Related literature
Product Overview
Product Name Lapaquistat acetate (Synonyms: TAK-475)
CAS189060-13-7
FormulaC33H41ClN2O9
MW645.14
MDLMFCD06407873
Appearance White to off-white powder
Storage conditionStore short-term at 0-4°C or long-term at -20°C in a dry, dark place.
Product details

Lapaquistat acetate, a potent squalene synthase inhibitor, impedes the conversion of farnesyl diphosphate (FPP) to squalene, a key step in cholesterol synthesis. Utilized in treating Mevalonate Kinase Deficiency (MKD), an autosomal recessive disorder, it significantly reduces low-density lipoprotein cholesterol levels. However, its use may be accompanied by liver damage, a known side effect that warrants monitoring.

 


Related
Sorry, no related items
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays